Dynavax to Present at the Oppenheimer Healthcare Conference
BERKELEY, Calif., Oct 20, 2009 (BUSINESS WIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) announced today that it plans to present at the Oppenheimer 20th Annual Healthcare Conference on Tuesday, November 3, 2009 at 10:15 am EST (7:15 am PST) at the Waldorf Astoria Hotel in New York.
Dino Dina, M.D., President and Chief Executive Officer of Dynavax, will provide a corporate overview presentation. To access the live webcast and the subsequent archived recording of the presentation, please log onto Dynavax's website at http://investors.dynavax.com/newsevents.cfm.
About Dynavax
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. The Company's lead product candidate is HEPLISAVTM, a Phase 3 investigational adult hepatitis B vaccine designed to provide more rapid and increased protection with fewer doses than current licensed vaccines. For more information visit www.dynavax.com.
SOURCE: Dynavax Technologies Corporation
Dynavax Technologies Corporation
Amy Figueroa, 510-665-7211
Investor Relations and Corporate Communications
afigueroa@dynavax.com
Copyright Business Wire 2009